Cargando…
Targeted multidrug delivery system to overcome chemoresistance in breast cancer
Chemotherapy has been widely used in breast cancer patients to reduce tumor size. However, most anticancer agents cannot differentiate between cancerous and normal cells, resulting in severe systemic toxicity. In addition, acquired drug resistance during the chemotherapy treatment further decreases...
Autores principales: | Tang, Yuan, Soroush, Fariborz, Tong, Zhaohui, Kiani, Mohammad F, Wang, Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5268372/ https://www.ncbi.nlm.nih.gov/pubmed/28176940 http://dx.doi.org/10.2147/IJN.S124770 |
Ejemplares similares
-
A Biomimetic Microfluidic Tumor Microenvironment Platform Mimicking the EPR Effect for Rapid Screening of Drug Delivery Systems
por: Tang, Yuan, et al.
Publicado: (2017) -
Targeting Cancer Stem Cells to Overcome Chemoresistance
por: Nunes, Toni, et al.
Publicado: (2018) -
Targeting heparanase overcomes chemoresistance and diminishes relapse in myeloma
por: Ramani, Vishnu C., et al.
Publicado: (2015) -
Cisplatin for cancer therapy and overcoming chemoresistance
por: Ranasinghe, Ranmali, et al.
Publicado: (2022) -
Editorial: Drug resistance in breast cancer – mechanisms and approaches to overcome chemoresistance
por: Raman, Dayanidhi, et al.
Publicado: (2023)